FDA To Issue Remarketer Labeling Regs, Monitor Registration System
This article was originally published in The Gray Sheet
Executive Summary
Device remarketers that label serviced devices as "ready for clinical use" under a recently proposed voluntary registration system will be subject to FDA enforcement action if the devices do not meet performance specifications, according to FDA staffers.